Global Slimming Aids Market Trends

Statistics for the 2023 & 2024 Global Slimming Aids market trends, created by Mordor Intelligence™ Industry Reports. Global Slimming Aids trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Market Trends of Global Slimming Aids Industry

The Natural Products Segment is Expected to Hold Significant Share in the Slimming Aids Market Over the Forecast Period

Natural or herbal supplements are among those that patients frequently utilize to lose weight. In human trials, these natural compounds have been shown to be efficient and secure in managing body weight. Natural products have the potential to serve as sources of nutraceuticals or medications to control body weight, including catechins, capsaicin, conjugated linoleic acid, fucoxanthin, soy isoflavone, glabridin, astaxanthin, and cyaniding-3-glucoside. The natural product segment is expected to witness significant growth in the slimming aids market over the forecast period owing to factors such as increasing incidence of obesity, higher adoption among consumers, fewer side effects, and long-term effects.

For instance, according to a report published by the Centers for Disease Control and Prevention (CDC) in September 2023, in 2022, the prevalence of adult obesity was 35% in the United States. The adult obesity prevalence rate has risen by 35% in the last ten years. This rising prevalence rate of obesity is expected to increase the demand for slimming aids. Such a high burden of obesity is expected to contribute to the demand for natural slimming aids, thereby fueling the growth of the studied segment over the forecast period.

The rising product launches by various key market players are also contributing to segment growth. For instance, in July 2022, Herbalife launched a new weight management product, Fat Release, based on a fiber derived from prickly pear cactus, Litramine, that helps control fat formation in the body.

Thus, owing to the aforementioned factors, such as increasing obesity and the rising demand for natural products along with increasing product launches, the market is expected to grow over the forecast period.

Global Slimming Aids Market: Top 5 obese OECD countries (in percentage) in the world, 2023

North America is Expected to Hold a Notable Share in the Marker Over the Forecast Period

North America is expected to hold a significant share in the slimming aids material market over the forecast period. Factors such as the rising prevalence of obesity, the rising demand for effective weight loss, and the growing weight management among the population are expected to boost the growth of the market in this region.

The United States is facing a serious concern related to obesity. For instance, according to a report published by the World Obesity Federation in January 2024, the United States ranks 10th globally for obesity. This alarming rise in obesity cases in the country is expected to drive significant growth in the slimming aids market. According to a report published by the Centers for Disease Control and Prevention (CDC) in September 2023, the states with a higher adult obesity prevalence include Alabama, Arkansas, Delaware, Georgia, Indiana, Iowa, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Nebraska, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Virginia, West Virginia, and Wisconsin. Thus, the high burden of obesity among the population is expected to increase the demand for weight loss products and supplements, thereby boosting the market growth in this region.

The rising product approvals and launches by various key market players in the region are also contributing to the market growth. For instance, in November 2023, the United States Food and Drug Administration approved Lilly's Zepbound (tirzepatide) for chronic weight management, a new option for the treatment of obesity or overweight with weight-related medical problems. Such product launches are expected to drive market growth. In late 2024, Novo Nordisk planned to make commercial availability of Wegovy, a weight-loss drug in Canada. In August 2022, Currax launched One Size Does Not Fit All, a branded project to bolster the benefits of meds for obesity and promote a personalized approach to weight loss.

Thus, owing to the aforementioned factors, such as the increasing burden of obesity, high demand for effective weight loss, and the rising product launches by key market players, the market is expected to grow over the forecast period.

Global Slimming Aids Market: Slimming Aids Market - Growth Rate by Region

Slimming Aids Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)